Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Medisorb Naltrexone Challenge Study
NCT01218984Phase 2Completed
- Sponsor
- Alkermes
- Start
- Mar 2002
- Primary completion
- May 2003
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of naltrexone in opioid use disorder (OUD) (3 arms), sponsored by Alkermes. Primary endpoint: Slope Change From Baseline for Pupil Size at 4 weeks. Started Mar 2002; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01218984.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218984.